To hear about similar clinical trials, please enter your email below
Trial Title:
Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion
NCT ID:
NCT05776732
Condition:
Tumour
Conditions: Keywords:
PICC
medical adhesive-related skin injury
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
3M CaviionTM
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
3M CaviionTM
Description:
3M CaviionTM is mainly composed of acrylate trimer, non-toxic, alcohol-free, and
compatible with chlorhexidine gluconate and povidone iodine.
Arm group label:
CaviionTM group
Summary:
Malignant tumor patients are at high risk of medical adhesive-related skin
injury（MARSI）.MARSI can cause local skin ulceration, increase the difficulty of fixation
and maintenance frequency, even cause unplanned extubation, and increase the pain and
economic burden of the patient's re-installation.Malignant tumor patients with long-term
PICC are prone to MARSI.CaviionTM can form a protective film on the skin.Applying
CaviionTM before using the adhesive can effectively protect the skin and reduce the
occurrence of rash.In China, CaviionTM is mostly used in infants and young children, but
adults lack corresponding report and application data.Therefore, it is necessary to carry
out corresponding randomized controlled study on adult patients, especially malignant
tumors
Detailed description:
The incidence of medical viscose-related skin injury after PICC intubation is as high as
33.15%. The main types of injury are mechanical injury, moisture-related skin injury,
contact dermatitis 8.02%, folliculitis.After radiotherapy and chemotherapy, patients with
malignant tumors interfere with the formation of new damaged skin cells.Large doses of
immunosuppressive agents further weaken the skin barrier and are prone to skin metabolism
and immune function disorder.In this study, patients with malignant tumor after PICC
intubation were randomly assigned.The experimental group uses CaviionTM, and the control
group does not use CaviionTM. Observe the skin condition one month after the tube
placement
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- For malignant tumor patients newly implanted with PICC,indwelling catheter for more
than 1 month，Conduct catheter maintenance in my hospital during observation
Exclusion Criteria:
- People with skin disease around PICC tube，Psychopath
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
石芸
Address:
City:
Hangzhou
Zip:
310009
Country:
China
Start date:
March 7, 2022
Completion date:
December 30, 2023
Lead sponsor:
Agency:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Agency class:
Other
Source:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05776732
